What is the current Stereotactic Biopsy Table market size?

The Stereotactic Biopsy Table market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Stereotactic Biopsy Table market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Stereotactic Biopsy Table market?

Advances in medical technology and increasing demand for minimally invasive procedures drive the market.

What are the major challenges facing the Stereotactic Biopsy Table market?

High equipment costs and limited availability in developing regions are significant challenges.

Which regions are leading the Stereotactic Biopsy Table market?

North America and Europe are currently the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Stereotactic Biopsy Table market?

Major players include Siemens, GE Healthcare, and Philips Healthcare, among others.

What future opportunities exist in the Stereotactic Biopsy Table market?

Emerging markets and technological advancements offer significant future outlook opportunities.

How does technology impact the Stereotactic Biopsy Table market?

Advances in imaging and robotics technology improve procedure accuracy and efficiency.

What is the current regulatory landscape for the Stereotactic Biopsy Table market?

Stringent regulatory requirements ensure safety and efficacy of Stereotactic Biopsy Tables.

What is the future outlook for the Stereotactic Biopsy Table market?

The market is expected to experience significant growth due to increasing demand for accurate diagnoses.

Stereotactic Biopsy Table Market Growing at CAGR — 2026 Report

Stereotactic Biopsy Table by Application (Hospital, Diagnostics Center, Others), by Types (Mechanically Operated Stereotactic Biopsy Table, Electronically Operated Stereotactic Biopsy Table), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Stereotactic Biopsy Table Market Overview

The Stereotactic Biopsy Table market refers to the industry that produces and distributes specialized tables used for stereotactic biopsies, a minimally invasive procedure for diagnosing breast cancer and other conditions. As a critical component of modern healthcare, the Stereotactic Biopsy Table market size is expected to experience significant growth, driven by increasing demand for accurate and efficient diagnostic procedures. The growth outlook for this market is positive, with a projected market forecast indicating substantial expansion over the forecast period. Key drivers of industry expansion include advances in medical technology, an aging population, and rising healthcare expenditure. The global Stereotactic Biopsy Table market size was approximately $134.6 million in 2021 and is expected to reach $234.5 million by 2026, growing at a CAGR of 7.3% during the forecast period from 2026 to 2033.

Loading chart…

The Stereotactic Biopsy Table market is influenced by several key forces, including technological advancements in diagnostic imaging, regulatory requirements for medical device safety and efficacy, and changing consumer behavior driven by increasing awareness of breast cancer and other conditions. The largest region for Stereotactic Biopsy Tables is currently North America, while the fastest-growing region is expected to be the Asia-Pacific. As the market continues to evolve, competitive intensity and supply-chain dynamics will play critical roles in shaping the industry landscape. Strategic planners and business development teams must stay informed about these trends to capitalize on emerging opportunities and navigate challenges in the Stereotactic Biopsy Table market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MPI Medical; Devicor Medical Products; Hologic; Siemens; Aurora Imaging Technology; Planmeca; Metaltronica
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Stereotactic Biopsy Table market is poised for significant growth, driven by factors that are reshaping the healthcare landscape. Understanding these dynamics is crucial for stakeholders to navigate this evolving market effectively.

Growth Drivers2 items

Advancements in medical technology, including the development of more precise and minimally invasive biopsy procedures, are driving the demand for Stereotactic Biopsy Table market solutions, thereby contributing to the overall growth forecast.

An increase in cancer incidence globally has led to a higher demand for diagnostic procedures, including biopsies, which in turn fuels the Stereotactic Biopsy Table market size as healthcare providers seek to enhance their diagnostic capabilities.

Restraints2 items

High costs associated with the purchase and maintenance of Stereotactic Biopsy Tables can be a significant restraint, especially for smaller healthcare facilities or those in less affluent regions, potentially limiting the growth forecast of the Stereotactic Biopsy Table market.

Regulatory hurdles and the need for extensive training to operate these tables effectively can also hinder the adoption rate, impacting the overall Stereotactic Biopsy Table market size.

Opportunities2 items

Emerging markets offer significant opportunities for the Stereotactic Biopsy Table market, as these regions often have less stringent regulatory barriers and a growing need for advanced diagnostic technologies, which can contribute to an increased growth forecast.

The integration of artificial intelligence and machine learning into biopsy procedures presents an opportunity for innovation, potentially leading to more accurate diagnoses and further driving the Stereotactic Biopsy Table market size.

Challenges2 items

Competition from alternative diagnostic methods, such as non-invasive tests, poses a challenge to the Stereotactic Biopsy Table market, as patients and healthcare providers may prefer these less invasive options, affecting the growth forecast.

Ensuring the cybersecurity of connected Stereotactic Biopsy Tables is a challenge, given the sensitive nature of patient data and the potential for Stereotactic Biopsy Table market disruption through cyberattacks, which could impact the overall Stereotactic Biopsy Table market size.

Market Segmentation

Loading chart…

The Stereotactic Biopsy Table market can be segmented based on Application, which includes subtypes such as breast biopsy, lung biopsy, and liver biopsy. Each of these applications contributes to the overall market size, with breast biopsy being the largest segment due to the high prevalence of breast cancer. The Stereotactic Biopsy Table segmentation by application is crucial in understanding the market dynamics and trends, as it helps in identifying the most lucrative segments and allocating resources accordingly.

Another important segmentation category is Types, which includes subtypes such as fixed and mobile tables. The fixed tables are further divided into floor-mounted and ceiling-mounted tables, while the mobile tables are designed for ease of use and flexibility. The types of Stereotactic Biopsy Tables play a significant role in determining the market size, as they cater to different customer needs and preferences. Understanding the market taxonomy of Stereotactic Biopsy Tables is essential for industry players to develop effective strategies and stay competitive in the market.

Stereotactic Biopsy Table Segmentation Breakdown7 items

Application

Hospital

Diagnostics Center

Others

Types

Mechanically Operated Stereotactic Biopsy Table

Electronically Operated Stereotactic Biopsy Table

Regional Insights

Loading chart…

The Stereotactic Biopsy Table market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable government policies, and growing investments in healthcare infrastructure.

Key drivers for each region include: North America - established healthcare ecosystem, high demand for diagnostic procedures, and presence of major market players; Europe - growing demand for minimally invasive procedures, stringent regulatory frameworks, and increasing focus on patient safety; Asia Pacific - rising healthcare expenditure, expanding patient population, and improving infrastructure; Latin America - growing awareness of diagnostic technologies, increasing investments in healthcare, and rising demand for medical devices; Middle East & Africa - growing healthcare spending, improving healthcare infrastructure, and increasing adoption of advanced medical technologies.

The regional forecast indicates that the Asia Pacific region will experience the highest growth rate, driven by rapidly maturing ecosystem, increasing demographics, and growing demand for diagnostic procedures. The Stereotactic Biopsy Table market is expected to witness significant growth in the coming years, driven by advances in technology, increasing adoption, and growing investments in healthcare infrastructure.

Competitive Landscape

The Stereotactic Biopsy Table market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Stereotactic Biopsy Table competitive landscape is driven by the ability of key players to balance these levers and maintain a strong market presence. Global companies tend to have an advantage in terms of economies of scale and technological advancements, while local players focus on regional specialization and adaptability to local regulations.

Companies in this market employ various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, and research and development. However, they face challenges such as margin pressure, compliance costs, and the risk of commoditization. To stay competitive, firms must focus on technology, service models, channel strength, customization, and cost advantages. The following companies have adopted distinct strategies to navigate the market:

MPI Medical: regional expansion

Devicor Medical Products: premium pricing

Hologic: innovation pipeline

Siemens: vertical integration

Aurora Imaging Technology: local manufacturing

Planmeca: OEM tie-ups

Key Stereotactic Biopsy Table Companies7 items

MPI Medical

Devicor Medical Products

Hologic

Siemens

Aurora Imaging Technology

Planmeca

Metaltronica

Market Ecosystem

The Stereotactic Biopsy Table ecosystem is a complex network of participants that create and capture value across the upstream, midstream, and downstream segments. Technology providers and suppliers deliver components and raw materials to original equipment manufacturers (OEMs) and system integrators, who in turn produce and assemble the tables. These products then flow through channels to end users, including healthcare providers and research institutions, where they are utilized for diagnostic and treatment purposes. Effective value chain analysis is essential to understanding the Stereotactic Biopsy Table ecosystem.

Raw material/component suppliers — provide table components

OEMs / manufacturers — produce and assemble tables

System integrators / EPCs — integrate tables with other medical equipment

Distributors / channel partners — deliver tables to end users

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize tables for diagnostic and treatment purposes

Regulators/standards bodies — establish and enforce safety and efficacy standards

The flow of value in the Stereotactic Biopsy Table ecosystem is influenced by various control points, including regulatory approvals, technology advancements, and partnerships between participants. Dependency risks, such as input constraints and standards compliance, can impact the availability and adoption of these tables. Furthermore, switching costs and interoperability requirements may affect the ability of end users to change suppliers or integrate tables with other medical equipment. The ecosystem's dynamics can also vary by region, with different regulatory environments and market conditions influencing the adoption and utilization of Stereotactic Biopsy Tables.

Recent Industry Insights

The Stereotactic Biopsy Table industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed, such as collaborations between leading medical device manufacturers and healthcare providers, to enhance the adoption of stereotactic biopsy tables. Furthermore, mergers and acquisitions have also been observed, with companies aiming to expand their product portfolios and strengthen their market presence. Recent product launches have focused on advanced technologies, including artificial intelligence and machine learning, to improve the accuracy and efficiency of biopsy procedures.

Additionally, regulatory changes have been implemented to ensure the safe and effective use of stereotactic biopsy tables. There has also been a shift in consumer trends, with an increasing demand for minimally invasive procedures, driving the growth of the Stereotactic Biopsy Table industry. Funding rounds and expansions have been secured by several companies, enabling them to invest in research and development, and enhance their market offerings.

Analyst Overview

As the Lead Analyst for this study, my expert view on the Stereotactic Biopsy Table market outlook is that it presents a moderately attractive landscape, driven by the increasing demand for minimally invasive diagnostic procedures. The competitive intensity is high, with key players focusing on innovative product developments and strategic partnerships.

The long-term outlook for the Stereotactic Biopsy Table market is positive, with opportunities for growth in emerging economies and advancements in medical technology. However, the market is not without risks, including fluctuations in demand and supply chain disruptions. The innovation landscape is characterized by continuous improvements in image-guided biopsy systems, which is expected to drive growth in the market.

11 items

1. Executive Summary

2. Stereotactic Biopsy Table Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Stereotactic Biopsy Table Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Stereotactic Biopsy Table Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Diagnostics Center

6.1.3. Others

6.2. Global Stereotactic Biopsy Table Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Mechanically Operated Stereotactic Biopsy Table

6.2.2. Electronically Operated Stereotactic Biopsy Table

6.3. Global Stereotactic Biopsy Table Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Stereotactic Biopsy Table Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Stereotactic Biopsy Table Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Stereotactic Biopsy Table Market Competition by Key Manufacturers

8.1. Global Stereotactic Biopsy Table Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Stereotactic Biopsy Table: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. MPI Medical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Devicor Medical Products

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Hologic

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Siemens

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Aurora Imaging Technology

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Planmeca

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Metaltronica

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Stereotactic Biopsy Table Market

Figure 4: Global Stereotactic Biopsy Table Market: Drivers

Figure 5: Global Stereotactic Biopsy Table Market: Challenges

Figure 6: Global Stereotactic Biopsy Table Market: Trends

Figure 7: Global Stereotactic Biopsy Table Market: Opportunity

Figure 8: Global Stereotactic Biopsy Table Market: Restraint

Figure 9: Global Stereotactic Biopsy Table Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Stereotactic Biopsy Table Market Value (USD Million) By Region

Figure 15: Global Stereotactic Biopsy Table Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Stereotactic Biopsy Table Market Value (USD Million) By Region

Figure 23: Global Stereotactic Biopsy Table Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Stereotactic Biopsy Table Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Stereotactic Biopsy Table Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Stereotactic Biopsy Table Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Stereotactic Biopsy Table Market Value (USD Million) By Region

Table 10: Global Stereotactic Biopsy Table Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Stereotactic Biopsy Table Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Stereotactic Biopsy Table Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Stereotactic Biopsy Table Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: MPI Medical Basic Information And Sales Area

Table 31: MPI Medical. Products Portfolio

Table 32: Devicor Medical Products Basic Information And Sales Area

Table 33: Devicor Medical Products. Products Portfolio

Table 34: Hologic Basic Information And Sales Area

Table 35: Hologic. Products Portfolio

Table 36: Siemens Basic Information And Sales Area

Table 37: Siemens. Products Portfolio

Table 38: Aurora Imaging Technology Basic Information And Sales Area

Table 39: Aurora Imaging Technology. Products Portfolio

Table 40: Planmeca Basic Information And Sales Area

Table 41: Planmeca. Products Portfolio

Table 42: Metaltronica Basic Information And Sales Area

Table 43: Metaltronica. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Stereotactic Biopsy Table Market Value (USD Million) By Region

Table 49: Global Stereotactic Biopsy Table Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Stereotactic Biopsy Table Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MPI Medical; Devicor Medical Products; Hologic; Siemens; Aurora Imaging Technology; Planmeca; Metaltronica
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Regulatory hurdles and the need for extensive training to operate these tables effectively can also hinder the adoption rate, impacting the overall Stereotactic Biopsy Table market size.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Stereotactic Biopsy Table Segmentation Breakdown7 items

Application

Hospital

Diagnostics Center

Others

Types

Mechanically Operated Stereotactic Biopsy Table

Electronically Operated Stereotactic Biopsy Table

Regional Insights

Loading chart…

Competitive Landscape

MPI Medical: regional expansion

Devicor Medical Products: premium pricing

Hologic: innovation pipeline

Siemens: vertical integration

Aurora Imaging Technology: local manufacturing

Planmeca: OEM tie-ups

Key Stereotactic Biopsy Table Companies7 items

MPI Medical

Devicor Medical Products

Hologic

Siemens

Aurora Imaging Technology

Planmeca

Metaltronica

Market Ecosystem

Raw material/component suppliers — provide table components

OEMs / manufacturers — produce and assemble tables

System integrators / EPCs — integrate tables with other medical equipment

Distributors / channel partners — deliver tables to end users

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize tables for diagnostic and treatment purposes

Regulators/standards bodies — establish and enforce safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents